Syneos Health_rgb_r.jpg
Syneos Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 janv. 2023 16h31 HE | Syneos Health, Inc.
MORRISVILLE, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer...
Syneos Health_rgb_r.jpg
Syneos Health Releases 2023 Health Trends
01 déc. 2022 07h30 HE | Syneos Health, Inc.
MORRISVILLE, N.C., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 2023 Health Trends:...
Syneos Health_rgb_r.jpg
Syneos Health Reports Third Quarter 2022 Results
04 nov. 2022 06h10 HE | Syneos Health, Inc.
Revenue for the third quarter of $1,336.2 million decreased 0.9% on a reported basis and increased 2.2% on a constant currency basis year-over-year.Clinical Solutions net new business awards and...
Syneos Health_rgb_r.jpg
Syneos Health Appoints William E. Klitgaard Independent Director
14 oct. 2022 16h45 HE | Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of William E....
Syneos Health_rgb_r.jpg
Syneos Health Releases Annual Sustainability Report
05 oct. 2022 07h00 HE | Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released its 2021 Sustainability Report....
Syneos Health_rgb_r.jpg
Syneos Health to Present at the 2022 Baird Global Healthcare Conference
30 août 2022 17h20 HE | Syneos Health, Inc.
MORRISVILLE, N.C, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer...
Syneos Health_rgb_r.jpg
Syneos Health to Present at Upcoming Investor Conferences
24 mai 2022 07h01 HE | Syneos Health, Inc.
MORRISVILLE, N.C., May 24, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced that the Company is scheduled to...
Michelle Keefe, Chief Executive Officer, Syneos Health
Syneos Health Names Michelle Keefe as Next Chief Executive Officer
29 avr. 2022 06h26 HE | Syneos Health, Inc.
Alistair Macdonald to Retire After 20 Years in Variety of Leadership Roles Michael Brooks Named Chief Operating Officer Company Reports First Quarter 2022 Results and Updates Full Year Guidance ...
Syneos Health_rgb_r.jpg
Syneos Health Reports First Quarter 2022 Results
29 avr. 2022 06h24 HE | Syneos Health, Inc.
Highlights Revenue for the first quarter of $1,336.3 million increased 10.5% on a reported basis and 11.7% on a constant currency basis year-over-year.Clinical Solutions net new business...
Syneos Health_rgb_r.jpg
Syneos Health Promotes Baba Shetty to President, Technology and Data Solutions, and Suma Ramadas to Executive Vice President, Medical Affairs
19 avr. 2022 08h00 HE | Syneos Health, Inc.
MORRISVILLE, N.C., April 19, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the promotions of two senior...